Short-term efficacy and safety of biologics and Janus kinase inhibitors for patients with atopic dermatitis: A systematic review and meta-analysis

BACKGROUND: In recent years, biologics targeting key cytokines and Janus kinase (JAK) inhibitors have demonstrated favorable efficacy and safety outcomes for atopic dermatitis (AD) therapy. To evaluate the short-term efficacy and safety of AD therapy involving biologics, JAK inhibitors, and their co...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qianyu, Cui, Lian, Hu, Yifan, Chen, Zeyu, Gao, Yunlu, Shi, Yuling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685203/
https://www.ncbi.nlm.nih.gov/pubmed/38034798
http://dx.doi.org/10.1016/j.heliyon.2023.e22014

Ejemplares similares

Ejemplares similares